These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 29300388)

  • 1. Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome editing and organoid transplantation.
    Roper J; Tammela T; Akkad A; Almeqdadi M; Santos SB; Jacks T; Yilmaz ÖH
    Nat Protoc; 2018 Feb; 13(2):217-234. PubMed ID: 29300388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A surgical orthotopic organoid transplantation approach in mice to visualize and study colorectal cancer progression.
    Fumagalli A; Suijkerbuijk SJE; Begthel H; Beerling E; Oost KC; Snippert HJ; van Rheenen J; Drost J
    Nat Protoc; 2018 Feb; 13(2):235-247. PubMed ID: 29300390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis.
    Roper J; Tammela T; Cetinbas NM; Akkad A; Roghanian A; Rickelt S; Almeqdadi M; Wu K; Oberli MA; Sánchez-Rivera FJ; Park YK; Liang X; Eng G; Taylor MS; Azimi R; Kedrin D; Neupane R; Beyaz S; Sicinska ET; Suarez Y; Yoo J; Chen L; Zukerberg L; Katajisto P; Deshpande V; Bass AJ; Tsichlis PN; Lees J; Langer R; Hynes RO; Chen J; Bhutkar A; Jacks T; Yilmaz ÖH
    Nat Biotechnol; 2017 Jun; 35(6):569-576. PubMed ID: 28459449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Colon Cancer Model Based on Colonoscopy Injection.
    Chang S
    Methods Mol Biol; 2021; 2224():147-152. PubMed ID: 33606213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protocol for efficient CRISPR-Cas9-mediated knock-in in colorectal cancer patient-derived organoids.
    Okamoto T; Natsume Y; Yamanaka H; Fukuda M; Yao R
    STAR Protoc; 2021 Dec; 2(4):100780. PubMed ID: 34585151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of CRISPR-Cas9 based gene editing to study the pathogenesis of colon and liver cancer using organoids.
    Ramakrishna G; Babu PE; Singh R; Trehanpati N
    Hepatol Int; 2021 Dec; 15(6):1309-1317. PubMed ID: 34596864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer.
    O'Rourke KP; Loizou E; Livshits G; Schatoff EM; Baslan T; Manchado E; Simon J; Romesser PB; Leach B; Han T; Pauli C; Beltran H; Rubin MA; Dow LE; Lowe SW
    Nat Biotechnol; 2017 Jun; 35(6):577-582. PubMed ID: 28459450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids.
    Liu X; Cheng Y; Abraham JM; Wang Z; Wang Z; Ke X; Yan R; Shin EJ; Ngamruengphong S; Khashab MA; Zhang G; McNamara G; Ewald AJ; Lin D; Liu Z; Meltzer SJ
    Cancer Lett; 2018 Nov; 436():109-118. PubMed ID: 30144514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
    Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination.
    Ideno N; Yamaguchi H; Okumura T; Huang J; Brun MJ; Ho ML; Suh J; Gupta S; Maitra A; Ghosh B
    Lab Invest; 2019 Jul; 99(8):1233-1244. PubMed ID: 30728464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
    Engelholm LH; Riaz A; Serra D; Dagnæs-Hansen F; Johansen JV; Santoni-Rugiu E; Hansen SH; Niola F; Frödin M
    Gastroenterology; 2017 Dec; 153(6):1662-1673.e10. PubMed ID: 28923495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome Editing with CRISPR-Cas9: A Budding Biological Contrivance for Colorectal Carcinoma Research and its Perspective in Molecular Medicine.
    Ray SK; Mukherjee S
    Curr Mol Med; 2021; 21(6):462-475. PubMed ID: 33213345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma.
    Kawasaki K; Fujii M; Sugimoto S; Ishikawa K; Matano M; Ohta Y; Toshimitsu K; Takahashi S; Hosoe N; Sekine S; Kanai T; Sato T
    Gastroenterology; 2020 Feb; 158(3):638-651.e8. PubMed ID: 31622618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland.
    Annunziato S; Kas SM; Nethe M; Yücel H; Del Bravo J; Pritchard C; Bin Ali R; van Gerwen B; Siteur B; Drenth AP; Schut E; van de Ven M; Boelens MC; Klarenbeek S; Huijbers IJ; van Miltenburg MH; Jonkers J
    Genes Dev; 2016 Jun; 30(12):1470-80. PubMed ID: 27340177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and immunofluorescent validation of gene knockouts in adult human colonic organoids using multi-guide RNA CRISPR-Cas9.
    Chan DKH; Collins SD; Buczacki SJA
    STAR Protoc; 2023 Mar; 4(1):101978. PubMed ID: 36598849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of human fetal hepatocyte organoids and CRISPR-Cas9-based gene knockin and knockout in organoid cultures from human liver.
    Hendriks D; Artegiani B; Hu H; Chuva de Sousa Lopes S; Clevers H
    Nat Protoc; 2021 Jan; 16(1):182-217. PubMed ID: 33247284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-Mediated Genome Editing of Mouse Small Intestinal Organoids.
    Schwank G; Clevers H
    Methods Mol Biol; 2016; 1422():3-11. PubMed ID: 27246017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakthrough Moments: Genome Editing and Organoids.
    Roper J; Yilmaz ÖH
    Cell Stem Cell; 2019 Jun; 24(6):841-842. PubMed ID: 31173713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating and Utilizing Murine Cas9-Expressing Intestinal Organoids for Large-Scale Knockout Genetic Screening.
    Kashfi H; Jinks N; Nateri AS
    Methods Mol Biol; 2020; 2171():257-269. PubMed ID: 32705648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multifunctional non-viral vector for the delivery of MTH1-targeted CRISPR/Cas9 system for non-small cell lung cancer therapy.
    Wang Y; Tang Y; Zhao XM; Huang G; Gong JH; Yang SD; Li H; Wan WJ; Jia CH; Chen G; Zhang XN
    Acta Biomater; 2022 Nov; 153():481-493. PubMed ID: 36162766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.